Charcoal, Activated

Charcoal, Activated

SCHEMBL6893799

[C].[C].[O].[O].[S]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0830136-B1 NEW CRYPTOPHYCINS FROM SYNTHESIS UNIV HAWAII (US) 2004-10-20 EP disclosed
US-6680311-B1 ANTICARCINOGENIC, ANTITUMOR AND ANTIPROLIFERATIVE AGENTS ELI LILLY AND COMPANY 2004-01-20 US disclosed
EP-0869786-B1 PHARMACEUTICAL COMPOUNDS LILLY CO ELI (US) 2003-03-05 EP disclosed
US-20020128185-A1 Pharmaceutical compounds HAWAII, UNIVERSITY OF 2002-09-12 US disclosed
EP-0792875-B1 Cryptophycin derivatives and their use as anti-microtubule agents LILLY CO ELI (US) 2001-05-09 EP disclosed
US-6180679-B1 PARASITICIDE ELI LILLY AND COMPANY 2001-01-30 US disclosed
US-6143909-A EPOXIDATION; PRODUCING CRYPTOPHYCIN COMPOUNDS HAVING AN EPOXIDE FUNCTIONALITY ELI LILLY AND COMPANY (US) 2000-11-07 US disclosed
US-6133457-A CRYPTOPHYCIN COMPOUNDS HAVING ANTIMICROTUBULE ACTIVITY; ANTIMETABOLITES ELI LILLY AND COMPANY (US) 2000-10-17 US disclosed
US-6013626-A TO INHIBIT THE PROLIFERATION OF MAMMALIAN CELLS; ANTITUMOR AGENTS THE UNIVERSITY OF HAWAII (US) 2000-01-11 US disclosed
EP-0957912-A4 1999-12-22 EP disclosed
EP-0957912-A1 PHARMACEUTICAL COMPOUNDS ELI LILLY AND COMPANY (US) 1999-11-24 EP disclosed
US-5977387-A Process for preparing pharmaceutical compounds ELI LILLY AND COMPANY (US) 1999-11-02 US disclosed
EP-0870501-A1 Use of specific cryptophycin derivatives for the manufacture of a medicament in the treatment of fungal infections ELI LILLY AND COMPANY (US) 1998-10-14 EP disclosed
EP-0861838-A2 Process and intermediates for preparing cryptophycin compounds ELI LILLY AND COMPANY (US) 1998-09-02 EP disclosed
EP-0861839-A1 Selective epoxidation process for preparing cryptophycin compounds and intermediates ELI LILLY AND COMPANY (US) 1998-09-02 EP disclosed
WO-1998008506-A1 PHARMACEUTICAL COMPOUNDS ELI LILLY AND COMPANY (US) 1998-03-05 WO disclosed
EP-0792875-A1 Cryptophycin derivatives and their use as anti-microtubule agents ELI LILLY AND COMPANY (US) 1997-09-03 EP disclosed